• Jump to main navigation
  • Jump to content
U of U Health
  • Billing & Insurance
  • MyChart
Search
  • Find A U of U Health Doctor
  • All U of U Health Services
  • All U of U Health Locations
  • For All U of U Health Patients & Visitors
    • Patient Services
      • Questions About Your Bill?
      • Urgent Care
      • Where to Stay
      • Patients & Family Services
      • Clinical Trials
    • University of Utah Hospital
      • University of Utah Hospital
      • Staying at the Hospital
      • Parking & Valet
      • Looking for Another Location?
    • General Questions
      • 801-581-2668
      • Find an Interpreter
      • About U of U Health
  • Billing & Insurance
  • MyChart
  • Search

Frederic C. Clayton, MD

  • Clinical Information
  • Academic Information
  • Clinical Trials
  • Patient Resources
  • Videos & News
No Rating Available?
In order to provide our patients and visitors with the most accurate and useful information, we only post physician satisfaction data when a physician has received a minimum of 30 returned surveys. For this provider, we have not yet received the minimum.
0 out of 5 Patient Rating

Languages Spoken: English

Dr. Clayton's recent work has focused on the immunologic aspects of allergic diseases.

Specialties

  • Pathology, Anatomical

Board Certification and Academic Information

Academic Departments Pathology - Professor
Academic Divisions Anatomic Pathology
Board Certification American Board of Pathology (Sub: Anatomic Path)

Dr. Clayton's recent work has focused on the immunologic aspects of allergic diseases.

Academic Locations

Board Certification and Academic Information

Academic Departments Pathology - Professor
Academic Divisions Anatomic Pathology
Board Certification American Board of Pathology (Sub: Anatomic Path)

Education History

Residency University of Utah School of Medicine
Clinical Pathology
Resident, 1987
Fellowship M.D. Anderson Cancer Center
Anatomic Pathology
Fellow, 1981
Fellowship University of Minnesota Hospitals
Surgical Pathology
Fellow, 1980
Residency Stanford University Medical Center
Anatomic Pathology
Resident, 1979
Internship Stanford University Medical Center
Anatomic & Clinical Pathology
Intern, 1978
Professional Medical Washington University
Medicine
M.D., 1977
Undergraduate Rice University

B.A., 1973

Selected Publications - Journal Articles

Journal Article

  1. Peterson K, Clayton F, Qeadan F, Gorman D, Robson J, Allen-Brady K, Fang JC (2020). Esophageal Eosinophilia Is Common Among Relatives of Eosinophilic Esophagitis Patients. Clin Gastroenterol Hepatol, 20(5), e957-e963.
  2. COREOS Collaborators, Ma C, Schoepfer AM, Dellon ES, Bredenoord AJ, Chehade M, Collins MH, Feagan BG, Furuta GT, Gupta SK, Hirano I, Jairath V, Katzka DA, Pai RK, Rothenberg ME, Straumann A, Aceves SS, Alexander JA, Arva NC, Atkins D, Biedermann L, Blanchard C, Cianferoni A, Ciriza de Los Rios C, Clayton F, Davis CM, de Bortoli N, Dias JA, Falk GW, Genta RM, Ghaffari G, Gonsalves N, Greuter T, Hopp R, Hsu Blatman KS, Jensen ET, Johnston D, Kagalwalla AF, Larsson HM, Leung J, Louis H, Masterson JC, Menard-Katcher C, Menard-Katcher PA, Moawad FJ, Muir AB, Mukkada VA, Penagini R, Pesek RD, Peterson K, Putnam PE, Ravelli A, Savarino EV, Schlag C, Schreiner P, Simon D, Smyrk TC, Spergel JM, Taft TH, Terreehorst I, Vanuytsel T, Venter C, Vieira MC, Vieth M, Vlieg-Boerstra B, von Arnim U, Walker MM, Wechsler JB, Woodland P, Woosley JT, Yang GY, Zevit N, Safroneeva E (2021). Development of a core outcome set for therapeutic studies in eosinophilic esophagitis (COREOS). J Allergy Clin Immunol, 149(2), 659-670.
  3. Ma C, Schoepfer AM, Safroneeva E, COREOS Collaborators, COREOS Collaborators (2021). Development of a Core Outcome Set for Therapeutic Studies in Eosinophilic Esophagitis (COREOS): An International Multidisciplinary Consensus. Gastroenterology, 161(3), 748-755.
  4. Ma C, Schoepfer AM, Safroneeva E, COREOS Collaborators (2021). A Summary of the Meetings of the Development of a Core Outcome Set for Therapeutic Studies in Eosinophilic Esophagitis (COREOS) International Multidisciplinary Consensus. Gastroenterology, 161(3), 778-784.
  5. Al-Rabadi LF, Caza T, Trivin-Avillach C, Rodan AR, Andeen N, Hayashi N, Williams B, Revelo MP, Clayton F, Abraham J, Lin E, Liou W, Zou CJ, Ramkumar N, Cummins T, Wilkey DW, Kawalit I, Herzog C, Storey A, Edmondson R, Sjoberg R, Yang T, Chien J, Merchant M, Arthur J, Klein J, Larsen C, Beck LH Jr (2021). Serine Protease HTRA1 as a Novel Target Antigen in Primary Membranous Nephropathy. J Am Soc Nephrol.
  6. Dong ZM, Lin E, Wechsler ME, Weller PF, Klion AD, Bochner BS, Delker DA, Hazel MW, Fairfax K, Khoury P, Akuthota P, Merkel PA, Dyer AM, Langford C, Specks U, Gleich GJ, Chinchilli VM, Raby B, Yandell M, Clayton F (2020). Pulmonary Eosinophilic Granulomatosis with Polyangiitis Has IgG4 Plasma Cells and Immunoregulatory Features. Am J Pathol, 190(7), 1438-1448.
  7. Saffari H, Peterson KA, Leiferman KM, Stabin MG, Krstyen JJ, Clayton FC, Pease LF 3rd, Yap JT, Hoffman JM, Gleich GJ (2019). Oral Administration of 99mTechnetium-Labeled Heparin in Eosinophilic Esophagitis. Mayo Clin Proc, 95(3), 449-458.
  8. Peterson KA, Gleich GJ, Limaye NS, Crispin H, Robson J, Fang J, Saffari H, Clayton F, Leiferman KM (2019). Eosinophil granule major basic protein 1 deposition in eosinophilic esophagitis correlates with symptoms independent of eosinophil counts. Dis Esophagus, 32(11).
  9. Swanson EA, March JK, Clayton F, Couturier MR, Arcega R, Smith R, Evason KJ (2018). Epithelial Inclusions in Gallbladder Specimens Mimic Parasite Infection: Histologic and Molecular Examination of Reported Cystoisospora belli Infection in Gallbladders of Immunocompetent Patients. Am J Surg Pathol, 42(10), 1346-1352.
  10. Peterson KA, Yoshigi M, Hazel MW, Delker DA, Lin E, Krishnamurthy C, Consiglio N, Robson J, Yandell M, Clayton F (2018). RNA sequencing confirms similarities between PPI-responsive oesophageal eosinophilia and eosinophilic oesophagitis. Aliment Pharmacol Ther, 48(2), 219-225.
  11. Li L, Luo C, Song Z, Reyes-Vargas E, Clayton F, Huang J, Jensen P, Chen X (2017). Association of anti-HER2 antibody with graphene oxide for curative treatment of osteosarcoma. Nanomedicine, 14(2), 581-593.
  12. Clayton F, Peterson K (2017). Eosinophilic Esophagitis: Pathophysiology and Definition. Gastrointest Endosc Clin N Am, 28(1), 1-14.
  13. Eroh GD, Clayton FC, Florell SR, Cassidy PB, Chirife A, Marn CF, Valenzuela LO, Campbell MS, Seger J, Rowntree VJ, Leachman SA (2017). Cellular and ultrastructural characterization of the grey-morph phenotype in southern right whales (Eubalaena australis). PLoS One, 12(2), e0171449.

Case Report

  1. Gutnik L, Goold E, Madsen J, Clayton F, Varghese T, Glasgow R (2020). Primary Esophageal Angiosarcoma. Ann Thorac Surg, 111(5), e365-e367.

Letter

  1. Kator S, Zurko J, Webb BJ, Balatico MA, Clayton F, Palmer CA, Konopa K, Motyckova G, Ford CD, Ostronoff F (2020). Disseminated toxoplasmosis and haemophagocytic lymphohistiocytosis following chimeric antigen receptor T-cell therapy. [Letter to the editor]. Br J Haematol, 189(1), e4-e6.
  2. Poole A, Girard N, Clayton F, Tantravahi SK (2016). Rapid onset of hemophagocytic lymphohistiocytosis in a patient with refractory chronic lymphocytic leukemia treated with ibrutinib. [Letter to the editor]. Leuk Lymphoma, 58(5), 1258-1261.

Site Links

  • Find an Interpreter
  • About Us
  • Academics & Research
  • Billing
  • Jobs
  • Giving
  • Maps & Directions
  • Newsroom
  • Referring Providers

Helpful Links

  • Patient Rights & Responsibilities
  • Disclaimer
  • Privacy Statement
  • DNV GL Public Information Policy Statement
  • Non-Discrimination Policy
  • Surprise Billing Rights
  • Webmaster

Contact Us

University of Utah Health

50 North Medical Drive
Salt Lake City, UT 84132

801-581-2121

  • Facebook
  • Twitter
  • Youtube
  • Instagram

University of Utah

All clinical services and programs are part of University of Utah Health Hospitals and Clinics.

Copyright © 2022 University of Utah Health